DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Riethmueller J, Junge S, Schroeter TW. et al.
Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis.
Infection 2009;
37 (05) 418-423
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.